ApoE Isoforms Inhibit Amyloid Aggregation of Proinflammatory Protein S100A9

Topic: Inflammation, microglia and astrocytes

Increasing evidence suggests that the calcium-binding and proinflammatory protein S100A9 is an important player in neuroinflammation-mediated Alzheimer's disease (AD). The amyloid co-aggregation of S100A9 with amyloid-β (Aβ) is an important hallmark of this pathology. Apolipoprotein E (ApoE) is also known to be one of the important genetic risk factors of AD. ApoE primarily exists in three isoforms, ApoE2 (Cys112/Cys158), ApoE3 (Cys112/Arg158), and ApoE4 (Arg112/Arg158). Even though the difference lies in just two amino acid residues, ApoE isoforms produce differential effects on the neuroinflammation and activation of the microglial state in AD. Here, we aim to understand the effect of the ApoE isoforms on the amyloid aggregation of S100A9. We found that both ApoE3 and ApoE4 suppress the aggregation of S100A9 in a concentration-dependent manner, even at sub-stoichiometric ratios compared to S100A9. These interactions lead to a reduction in the quantity and length of S100A9 fibrils. The inhibitory effect is more pronounced if ApoE isoforms are added in the lipid-free state versus lipidated ApoE. We found that, upon prolonged incubation, S100A9 and ApoE form low molecular weight complexes with stochiometric ratios of 1:1 and 2:1, which remain stable under SDS-gel conditions. These complexes self-assemble also under the native conditions; however, their interactions are transient, as revealed by glutaraldehyde cross-linking experiments and molecular dynamics (MD) simulation. MD simulation demonstrated that the lipid-binding C-terminal domain of ApoE and the second EF-hand calcium-binding motif of S100A9 are involved in these interactions. We found that amyloids of S100A9 are cytotoxic to neuroblastoma cells, and the presence of either ApoE isoforms does not change the level of their cytotoxicity. A significant inhibitory effect produced by both ApoE isoforms on S100A9 amyloid aggregation can modulate the amyloid-neuroinflammatory cascade in AD.

Key findings

• Increasing evidence suggests that the calcium-binding and proinflammatory protein S100A9 is an important player in neuroinflammation-mediated Alzheimer's disease (AD).
• We found that both ApoE3 and ApoE4 suppress the aggregation of S100A9 in a concentration-dependent manner, even at sub-stoichiometric ratios compared to S100A9.
• The inhibitory effect is more pronounced if ApoE isoforms are added in the lipid-free state versus lipidated ApoE.
• We found that, upon prolonged incubation, S100A9 and ApoE form low molecular weight complexes with stochiometric ratios of 1:1 and 2:1, which remain stable under SDS-gel conditions.
• These complexes self-assemble also under the native conditions; however, their interactions are transient, as revealed by glutaraldehyde cross-linking experiments and molecular dynamics (MD) simulation.

New to this subject? Start with our plain-English guide: Genetics →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.3390/ijms25042114
• PubMed: 38396791
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{ghosh2024-38396791,
  author  = {Ghosh, Shamasree and Tamilselvi, Shanmugam and Williams, Chloe and Jayaweera, Sanduni W and Iashchishyn, Igor A and Šulskis, Darius and Gilthorpe, Jonathan D and Olofsson, Anders and others},
  title   = {{ApoE Isoforms Inhibit Amyloid Aggregation of Proinflammatory Protein S100A9}},
  journal = {International journal of molecular sciences},
  year    = {2024},
  doi     = {10.3390/ijms25042114},
  pmid    = {38396791},
  url     = {https://doi.org/10.3390/ijms25042114}
}

Related studies in Genetics

• Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations Biochemistry · 1999-04-01 · usefulness score 44/100
• Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan Molecular neurodegeneration · 2016-05-05 · usefulness score 38/100
• Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance Science Translational Medicine · 2011-06-29 · usefulness score 58/100
• Tau protein aggregation is associated with cellular senescence in the brain Aging cell · 2018-10-11 · usefulness score 41/100
• APP antisense oligonucleotides reduce amyloid-β aggregation and rescue endolysosomal dysfunction in Alzheimer's disease Brain · 2024-07-05 · usefulness score 52/100
• Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease Nanomedicine : nanotechnology, biology, and medicine · 2013-12-10 · usefulness score 41/100

Similar studies

• Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease 2014 · Genetics
• The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer's Disease 2020 · Genetics
• Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β 2021 · Genetics
• Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease 2006 · Genetics
• Isoform-specific binding of apolipoprotein E to beta-amyloid 1994 · Genetics
• ApoE and Aβ in Alzheimer's disease: accidental encounters or partners? 2014 · Genetics

More on Genetics

• A review that covers this ground Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: beyond the role of amyloid beta Neural regeneration research · 2024-01 · usefulness score 43/100
• Newest in this subject APH-1A and CDK5 Expression Correlates with Tau Hyperphosphorylation and Its Attenuation by Brahmi and Donep-M in STZ induced Alzheimer’s Disease Model Research Square · 2026-10-31 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Integrative systems biology identifies shared neuroimmune co-expression programmes across pulmonary tuberculosis and Alzheimer's disease Research Square · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Genetics →